|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.53 USD | -0.44% |
|
-2.58% | +48.52% |
| 05-01 | Transcript : G1 Therapeutics, Inc., Q1 2024 Earnings Call, May 01, 2024 | |
| 05-01 | Earnings Flash (GTHX) G1 THERAPEUTICS Reports Q1 Revenue $14.5M, vs. Street Est of $15.1M | MT |
G1 Therapeutics, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported revenue was USD 14.48 million compared to USD 12.95 million a year ago. Net loss was USD 10.22 million compared to USD 27.6 million a year ago.
Basic loss per share from continuing operations was USD 0.2 compared to USD 0.53 a year ago. Diluted loss per share from continuing operations was USD 0.2 compared to USD 0.53 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +48.52% | 238M | |
| +8.63% | 115B | |
| +13.17% | 107B | |
| -12.76% | 22.31B | |
| -3.99% | 21.6B | |
| -7.19% | 18.23B | |
| -39.93% | 17.62B | |
| +6.67% | 14.26B | |
| +33.90% | 12.37B | |
| -28.60% | 8.28B |
G1 THERAPEUTICS, INC. 
